The 9MMNon-Erosive Reflux Disease (NERD) Treatment Market is expected to offer an $ opportunity of USD XX Million over the analysis period. Market was estimated USD XX Million during 2023 and expected to grow at a significant CAGR XX% over the projected period. And by the end of 2033, the market is expected to touch USD XX Million.
Pipeline drugs expected to provide an opportunity of more than USD 7.5 billion during the forecast year.
+30 ongoing clinical trials
Disease Overview
Non-erosive reflux disease (NERD) is a subtype of gastroesophageal reflux disease (GERD) characterized by typical GERD symptoms, such as heartburn and acid regurgitation, in the absence of esophageal mucosal injury.
Report has deeply investigated patient’s presentation and tailored treatment
Report has Covered Granular-level Analysis in Each Mapped Market
Non-Erosive Reflux Disease (NERD) Disease Burden Analysis: (Result shown here is reflecting from meta-analysis, and CSP Analytics Solutions Analysis)
Our analysis shows that, the prevalence of Non-Erosive Reflux Disease (NERD) varies across regions but, its overall prevalence ranges from 50% and 70% of the GERD population especially in western countries. Moreover, annual progression rates for NERD to ERD ranged from 0% to 30%
This section explored the epidemiology associated with Non-Erosive Reflux Disease (NERD) across regions.
Experts indicated prevalence increased significantly across regions, but gaps in estimates persist.
Our research report has provided crystal clear view of prevalent pool across regions. Since epidemiology estimation accompanied with lot of complexity, our report has streamlined the estimation process for enhancing market understanding.
Report has also highlighted, impact of improvements in diagnosis, on diagnosis rate (%).
Non-Erosive Reflux Disease (NERD) Cases: 9MM
Non-Erosive Reflux Disease (NERD) accounts for XX million cases of Gastroesophageal reflux disease (GERD) in 9MM
Non-Erosive Reflux Disease (NERD) accounts for XX million cases of Gastroesophageal reflux disease (GERD) in United States
Non-Erosive Reflux Disease (NERD) accounts for XX million cases of Gastroesophageal reflux disease (GERD) in China
Non-Erosive Reflux Disease (NERD) accounts for XX million cases of Gastroesophageal reflux disease (GERD) in India
Non-Erosive Reflux Disease (NERD) accounts for XX million cases of Gastroesophageal reflux disease (GERD) in Japan
Non-Erosive Reflux Disease (NERD) accounts for XX million cases of Gastroesophageal reflux disease (GERD) in Rest of World
Treatment Landscape:
This report section deals with the treatment strategies adopted by healthcare professional while dealing across patients’ segments. Also provided gaps in current treatment and upcoming treatment options.
Currently, no vaccines are available for the prevention of RSV infections
Treatment of Non-Erosive Reflux Disease (NERD)’s requires holistic framework to address diverse set of patients accompanied with various type of Non-Erosive Reflux Disease (NERD). Collaboration among various specialties imperative to devise tailoring treatment plan. Efforts to encourage diagnosis rate and advocacy at patient and physician level is crucial to provide better therapeutic options.
Report section covers detailed around various types of available treatments
OTC Drugs
Prescription
Combination Therapy
Complementary Therapies
Also covers patient segment targeted by each therapy type: This section address concerns regarding unaddressed patient pool
Several companies and institutions collaborating to bring out the appropriate treatment solutions
Our report analysis revealed that, there are tremendous opportunities exits in the market in order to close the current market gaps
Recent clinical guidelines enable the streamlining the treatment approaches
Report has examined the how many and what type of cases refer to which type of therapy based on experts’ opinion analysis.
Patient Segment Coverage:
Drug
Targeted Patient Segment
OTC Drugs
XX
Prescription
XX
Combination Therapy
XX
Complementary Therapies
XX
Upcoming Therapy Assessment (Pipeline Analysis)
Report also provided promising therapy assessment including existing therapies, and upcoming therapy
Novel drug target assessment
Comparable efficacy and safety profiles of key drugs prescribed in each mapped geography
Expected launch of key pipeline assets
Report alsoinvestigated novel therapy development
Experts Opinion on the matter of accepting novel treatment options
Promising molecules advantages offer over existing therapy
Impact assessment of pipeline assets
Drug analogue analysis
Expected annual cost of therapy
Market space expected to be captured by emerging therapeutic options
Market Segmentation Analysis by:
By Treatment Type
OTC
Antacids
H2-receptor antagonists (H2RAs)
Proton pump inhibitors (PPIs)
Prescription
Prokinetics
Alginate-based formulations
Proton pump inhibitors (PPIs)
Combination Therapy
By Severity
Mild
Moderate
Severe
By Route of Administration
Injectable treatments
Oral treatments
Infusion treatments
By Gender
Male
Female
Market Enablers: Explored in the report
Increasing Prevalence: The prevalence of GERD, including NERD, has been on the rise globally due to factors such as changes in lifestyle, dietary habits, and obesity rates. This increasing prevalence drives demand for diagnostic and treatment options specifically tailored to NERD.
Untreated Prevalent Pool of Non-Erosive Reflux Disease (NERD)
Huge medical unmet need
Demand for Effective Treatment Options
Proliferation of novel treatment options
Advent of emerging therapy for developing tailoring treatment
Continued investments in research and developmental activities by pharmaceutical companies, and academic institutions contribute to the development of innovative diagnostic tools, treatments, and other therapies.
Market Challenges: Explored in the report
Patient Heterogeneity: Patients with NERD exhibit diverse symptoms and responses to treatment. Some may experience severe symptoms despite minimal esophageal inflammation, while others may have mild symptoms despite significant mucosal damage. This heterogeneity complicates treatment strategies and clinical trials.
Limited Treatment Efficacy
Chronic Nature and Recurrence
Research and development gaps
Lack of adequate treatment compliance and adherence
Mapped Geography: Nine Major Markets (9MM)
Report has fragmented the total market into five regions such as:
United States
5-Europe
Germany
France
Italy
Spain
United Kingdom
Rest of Europe
China
Japan
India
RoW (Rest of World)
Each mapped region has been examined at granular level based on below parameters:
United States Non-Erosive Reflux Disease (NERD) Treatment Market
Market Size and Forecast Model 2023-2033
Disease Overview
Current Treatment Approaches
Key Opinion Leader (KOL) Views
Disease Burden Analysis (Prevalence, Diagnosed, Treatable Prevalent Pool Analysis)
Disease Burden Analysis (Prevalence, Diagnosed, Treatable Prevalent Pool Analysis)
Diagnosis and Treatment Guidelines
Drug Share Analysis (%)
Drug Treatment Adherence and Compliance Rate (%)
Annual Cost of Therapy
Current Treatment Landscape and Upcoming therapy Assessment
Market Unmet Need Analysis
Key Players in the Market and their Market share (%)
By Country
United Kingdom
Germany
France
Italy
Spain
Rest of Europe
China Non-Erosive Reflux Disease (NERD) Treatment Market
Market Size and Forecast Model 2023-2033
Disease Overview
Current Treatment Approaches
Key Opinion Leader (KOL) Views
Disease Burden Analysis (Prevalence, Diagnosed, Treatable Prevalent Pool Analysis)
Diagnosis and Treatment Guidelines
Drug Share Analysis (%)
Drug Treatment Adherence and Compliance Rate (%)
Annual Cost of Therapy
Current Treatment Landscape and Upcoming therapy Assessment
Market Unmet Need Analysis
Key Players in the Market and their Market share (%)
India Non-Erosive Reflux Disease (NERD) Treatment Market
Market Size and Forecast Model 2023-2033
Disease Overview
Current Treatment Approaches
Key Opinion Leader (KOL) Views
Disease Burden Analysis (Prevalence, Diagnosed, Treatable Prevalent Pool Analysis)
Diagnosis and Treatment Guidelines
Drug Share Analysis (%)
Drug Treatment Adherence and Compliance Rate (%)
Annual Cost of Therapy
Current Treatment Landscape and Upcoming therapy Assessment
Market Unmet Need Analysis
Key Players in the Market and their Market share (%)
Japan Non-Erosive Reflux Disease (NERD) Treatment Market
Market Size and Forecast Model 2023-2033
Disease Overview
Current Treatment Approaches
Key Opinion Leader (KOL) Views
Disease Burden Analysis (Prevalence, Diagnosed, Treatable Prevalent Pool Analysis)
Diagnosis and Treatment Guidelines
Drug Share Analysis (%)
Drug Treatment Adherence and Compliance Rate (%)
Annual Cost of Therapy
Current Treatment Landscape and Upcoming therapy Assessment
Market Unmet Need Analysis
Key Players in the Market and their Market share (%)
Rest of the World Non-Erosive Reflux Disease (NERD) Treatment Market
Market Size and Forecast Model 2023-2033
Disease Overview
Current Treatment Approaches
Key Opinion Leader (KOL) Views
Disease Burden Analysis (Prevalence, Diagnosed, Treatable Prevalent Pool Analysis)
Diagnosis and Treatment Guidelines
Drug Share Analysis (%)
Drug Treatment Adherence and Compliance Rate (%)
Annual Cost of Therapy
Current Treatment Landscape and Upcoming therapy Assessment
Market Unmet Need Analysis
Key Players in the Market and their Market share (%)
Competitive Landscape (Existing and Pipeline Players):
Players in Market Space - Players explored in the report has been analyzed at various parameters. Analysis done around, product offerings, pipeline assets, In-licensing and out-licensing opportunities, financial health, market share, collaboration and partnership, patents, funding secures, technology outlook, future strategic move and investment.
Companies Profile:
AstraZeneca
Takeda Pharmaceutical Company
Pfizer
Ironwood Pharmaceuticals
Johnson & Johnson
Sun Pharmaceuticals
Cipla
Il-Yang Pharm. Co., Ltd.
Yooyoung Pharmaceutical Co., Ltd.
Others
Pipeline Companies:
Daewoong Pharmaceutical Co. LTD.
Chong Kun Dang Pharmaceutical
Il-Yang Pharm. Co., Ltd.
Phathom Pharmaceuticals, Inc.
Eisai Co., Ltd.
Reason to buy this report:
Fostering Understanding on Non-Erosive Reflux Disease (NERD) Disease Treatment Market
In Order to Understand the Market Potential
Opportunity Analysis (exist in the market for players)
